Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMPHISARC: HDM201 + Pazopanib in Advanced/Metastatic Soft Tissue Sarcomas
NCT05180695Phase 2Active, not recruiting
- Sponsor
- Centre Léon Bérard
- Start
- Apr 2022
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of siremadlin in soft tissue sarcoma (STS), sponsored by Centre Léon Bérard. Started Apr 2022; status: active, not recruiting.
02
Drugs
siremadlin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05180695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05180695.